Waters Collaborates with IonSense
The companies are collaborating to interface the Waters Acquity QDa Mass Detector with the IonSense DART ionization source.
On Jun 1, 2017, Waters announced that it will be collaborating with IonSense to interface the Waters Acquity QDa Mass Detector with the IonSense DART ionization source. The combination of the two products will enable the rapid generation of mass data directly from liquid or solid samples with little or no sample preparation. According to the companies, this tool will be useful for medicinal chemists monitoring reactions, forensic investigators, and product quality groups, among others.
“Since its introduction in 2013, the QDa detector has brought the benefits of high-quality mass spectral information to a broad spectrum of applications in a number of industries,” said Gary Harland, senior director, Mass Spectrometry Product Management, Waters Corporation in a statement. “Our collaborative engagement with IonSense promises to make mass spectral data accessible to even more customers and markets.”
Source: Waters
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
